Biotech Pre-Seed Investors & VC Firms
915 firms in this list, with a median first check of $250K. 237 of them lead rounds. Generated from verified public data and updated continuously.
Taihill Venture
CambridgePre-Seed–Seed
11 people
Qbic Fund
St-Denijs-WestremPre-Seed–Series A
18 people
Cure Ventures
BostonPre-Seed–Series A
20 people
Tal Ventures
Tel AvivPre-Seed–Late Stage
8 people
LVX Ventures
BangalorePre-Seed–Growth
1 person
growX Ventures
BangalorePre-Seed–Growth
13 people
MassVentures
WalthamPre-Seed–Seed$250K – $500K
9 people
Debiopharm Innovation Fund
LausannePre-Seed–Series A$1M – $5M
17 people
Adverb Ventures
San FranciscoPre-Seed–Series A$500K – $5M
8 people
Ontario Centre of Innovation
TorontoPre-Seed–Seed$500K
19 people
University of Cambridge Enterprise
CambridgePre-Seed–Seed
14 people
Innospark Ventures
BostonPre-Seed–Series A$2M
12 people
JC Capital
BeijingPre-Seed–Series A
11 people
Necessary Ventures
San FranciscoPre-Seed–Seed$1M – $2M
11 people
Newland Syndicate
LondonPre-Seed–Seed
23 people
FAST — by GETTYLAB
San FranciscoPre-Seed–Seed$100K
1 person
Heal Capital
BerlinPre-Seed–Series A$1.1M – $5.4M
13 people
Starlight Ventures
MiamiPre-Seed–Series B$100K – $3M
7 people
1517
TelluridePre-Seed–Seed$50K – $1M
6 people
Suncoast Ventures
Walnut CreekPre-Seed–Series A
15 people
Rhapsody Venture Partners
CambridgePre-Seed–Seed$500K – $2M
10 people
Taiwan Global Angels
BerkeleyPre-Seed–Series B$300K – $3M
19 people
UCL Technology Fund
LondonPre-Seed–Seed$320K – $9M
13 people
Quantonation
ParisPre-Seed–Series B
12 people
Related lists
Pre-Seed Investors & VC Firms (5569)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Biotech Investors & VC Firms (2475)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Biotech Seed Investors & VC Firms (2020)Fintech Pre-Seed Investors & VC Firms (1711)SaaS Pre-Seed Investors & VC Firms (1652)Biotech Series A Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Europe (1598)
Data sourced from public filings and firms' own websites — see our methodology.











































































































